Physician profile
Georges Ephrem
NPI 1366606972
$17,919.49
in general payments reported to CMS, 2019-2025
10 companies · $6,877 in 2025
The $6,877 reported for 2025 was more than what 93% of Adult Congenital Heart Disease providers received nationally (typical 2025 total: $272).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,533 · 2020: $14.46 · 2021: $4,111 · 2022: $1,711 · 2023: $3,649 · 2024: $23.25 · 2025: $6,877.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,789 · Honoraria: $2,000 · Food and Beverage: $1,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,789.40 |
| Honoraria | $2,000.00 |
| Food and Beverage | $1,760.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4,000.00 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $3,521.03 | 2022-2025 | Pascal, Evoque |
| Philips North America LLC | $3,329.59 | 2021-2025 | Igt Devices Undivided, (9520) Igt Devices Undivided |
| Abbott Laboratories | $3,294.78 | 2019-2025 | Triclip, Mitraclip, Amplatzer Amulet |
| Medtronic, INC. | $2,368.84 | 2021-2023 | Harmony |
| Medtronic Vascular, INC. | $1,204.45 | 2019 | |
| Cardiovascular Systems INC. | $114.71 | 2019 | |
| Boston Scientific Corporation | $37.71 | 2020-2024 | |
| Cardiva Medical, INC. | $36.48 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georges Ephrem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.